EXHIBIT 99.1
Shire Pharmaceuticals Group plc |  |
For immediate release
Shire to Present at the JPMorgan 22nd Annual Healthcare Conference
Basingstoke, UK – 7 January 2004– Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announces that it will present at the JPMorgan 22nd Annual Healthcare conference in San Francisco on Wednesday, 14 January 2004, at 11:30 am EST. Investors may access a live audio webcast of the presentation atwww.shire.com.
For further information please contact:
Investor Relations
| Souheil Salah | +44 1256 894 160 |
Notes to editors
Shire Pharmaceuticals Group plc
Shire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceutical company with a strategic focus on meeting the needs of the specialist physician and currently focuses on developing projects and marketing products in the areas of central nervous system (CNS), gastrointestinal (GI), and renal diseases. Shire has operations in the world’s key pharmaceutical markets (US, Canada, UK, France, Italy, Spain and Germany) as well as a specialist drug delivery unit in the US.
For further information on Shire, please visit the Company’s website:www.shire.com